BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15143368)

  • 21. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of anti-Anisakis simplex antibody levels on C3 and C4 complement components in human sera.
    García-Hernández P; Rodero M; Gisbert-Criado R; Puente P; Pelayo V; Andreu-Ballester JC; Cuéllar C
    J Helminthol; 2012 Jun; 86(2):197-201. PubMed ID: 21729389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S
    Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretory IgA and complement levels in patients with hookworm infection in Zaria.
    Musa BO; Onyemelukwe GC
    Afr J Med Med Sci; 2000 Jun; 29(2):111-4. PubMed ID: 11379439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoglobulins (IgG, IgA, IgM, IgE) and complement components (C3, C4 and C1-inhibitor) in chronic urticaria (author's transl)].
    Wüthrich B
    Dermatol Monatsschr; 1979 Mar; 165(3):191-7. PubMed ID: 467753
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pesticide exposure on serum immunoglobulin and complement levels.
    Undeğer U; Başaran N
    Immunopharmacol Immunotoxicol; 2001 Aug; 23(3):437-43. PubMed ID: 11694033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of UV radiation on interferon, immunoglobulins and complement components in serum from healthy individuals.
    Livden JK; Bjerke JR; Degre M; Matre R
    Photodermatol; 1987 Dec; 4(6):296-301. PubMed ID: 2451236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of postoperative serum immunoglobulin and complement component concentrations following gastric resection for carcinoma.
    Janssen CW; Tønder O; Matre R
    Acta Chir Scand; 1985; 151(1):63-7. PubMed ID: 3984658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoglobulins and the complement system in colorectal cancer].
    Codina Cazador A; Salvá Lacombe JA; Fernández-Llamazares Rodríguez J; Ruiz Feliu B; Codina Barreras A; Moreno Aguado V
    Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):143-8. PubMed ID: 2710997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients.
    Ozkan Y; Yardim-Akaydin S; Firat H; Calişkan-Can E; Ardiç S; Simşek B
    Anticancer Res; 2007; 27(2):1185-9. PubMed ID: 17465261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis.
    Yildirim B; Sezgin N; Sari R; Sevinc A; Hilmioglu F
    South Med J; 2002 Oct; 95(10):1158-62. PubMed ID: 12425501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The dynamics of the hormonal and tumor marker levels in response to adrenaline administration in lung cancer patients].
    Khudoleĭ VN; Velichko SA
    Vopr Onkol; 1992; 38(10):1209-17. PubMed ID: 1343147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Converse changes in serum levels of immunoglobulins (IgG, A and M) and complement components (C3, 4) during pregnancy].
    Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Amino N; Miyai K
    Rinsho Byori; 1991 Nov; 39(11):1195-8. PubMed ID: 1762197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
    Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
    Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.